Literature DB >> 25121007

Same dog bite and different outcome in two cases - case report.

Gadekar Rd1, Domple Vk1, Inamdar If1, Aswar Nr2, Doibale Mk3.   

Abstract

There is still no cure for rabies and survival from clinical rabies is extremely rare. It is a preventable disease if the post exposure prophylaxis is initiated in time and administered as per WHO guidelines including administration of rabies immunoglobulin. The role of passive rabies immunization products is to provide the immediate availability of neutralizing antibodies at the site of the exposure before it is physiologically possible for the patient to begin producing his or her own antibodies after vaccination. In this case report, the same dog has bitten to a boy and to an adult. Local wound treatment and use of human rabies immunoglobulin as well as gluteal region as a site of bite were the probable reasons for survival of the boy. On the other hand no local wound treatment, no use of rabies immunoglobulin and finger as a site of bite are the probable reasons for death of an adult due to rabies.

Entities:  

Keywords:  Death; Rabies; Rabies immunoglobulin; Treatment failure

Year:  2014        PMID: 25121007      PMCID: PMC4129300          DOI: 10.7860/JCDR/2014/9017.4468

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  4 in total

1.  Equine rabies immunoglobulin: a study on its clinical safety.

Authors:  D M Satpathy; T Sahu; T R Behera
Journal:  J Indian Med Assoc       Date:  2005-04

2.  Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey.

Authors:  M K Sudarshan; S N Madhusudana; B J Mahendra; N S N Rao; D H Ashwath Narayana; S Abdul Rahman; F -X Meslin; D Lobo; K Ravikumar
Journal:  Int J Infect Dis       Date:  2006-05-04       Impact factor: 3.623

3.  WHO Expert Consultation on rabies.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2005

4.  Post-exposure prophylaxis for rabies with ERIG and IDRV in children.

Authors:  T R Behera; D M Satapathy; A K Pratap; R M Tripathy
Journal:  J Commun Dis       Date:  2011-03
  4 in total
  2 in total

1.  Safety and efficacy of rabies immunoglobulin in pediatric patients with suspected exposure.

Authors:  Nicholas Hobart-Porter; Michal Stein; Naveh Toh; Novinyo Amega; Huy-Binh Nguyen; James Linakis
Journal:  Hum Vaccin Immunother       Date:  2021-02-09       Impact factor: 4.526

2.  Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial.

Authors:  Mark A Matson; Eran Schenker; Michal Stein; Vladislava Zamfirova; Huy-Binh Nguyen; Garrett E Bergman
Journal:  Hum Vaccin Immunother       Date:  2019-09-24       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.